Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Metipranolol hydrochloride |
Is a |
False |
Metipranolol (substance) |
Inferred relationship |
Some |
|
Product containing metipranolol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metipranolol (substance) |
Inferred relationship |
Some |
1 |
Metipranolol adverse reaction |
Causative agent (attribute) |
True |
Metipranolol (substance) |
Inferred relationship |
Some |
1 |
Allergy to metipranolol |
Causative agent (attribute) |
False |
Metipranolol (substance) |
Inferred relationship |
Some |
|
Metipranolol 0.3% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metipranolol (substance) |
Inferred relationship |
Some |
|
Metipranolol 0.1% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metipranolol (substance) |
Inferred relationship |
Some |
|
Metipranolol 0.1% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metipranolol (substance) |
Inferred relationship |
Some |
|
Metipranolol 0.3% ophthalmic solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metipranolol (substance) |
Inferred relationship |
Some |
|
Metipranolol 0.3% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metipranolol (substance) |
Inferred relationship |
Some |
|
Metipranolol-induced anterior uveitis (disorder) |
Causative agent (attribute) |
False |
Metipranolol (substance) |
Inferred relationship |
Some |
2 |
Allergy to metipranolol |
Causative agent (attribute) |
True |
Metipranolol (substance) |
Inferred relationship |
Some |
1 |
Metipranolol 0.3% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metipranolol (substance) |
Inferred relationship |
Some |
|
Metipranolol hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Metipranolol (substance) |
Inferred relationship |
Some |
|
Product containing metipranolol in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metipranolol (substance) |
Inferred relationship |
Some |
1 |
Product containing only metipranolol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metipranolol (substance) |
Inferred relationship |
Some |
1 |
Product containing only metipranolol in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metipranolol (substance) |
Inferred relationship |
Some |
1 |
Metipranolol 1 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metipranolol (substance) |
Inferred relationship |
Some |
1 |
Metipranolol 1 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metipranolol (substance) |
Inferred relationship |
Some |
1 |
Metipranolol 3 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metipranolol (substance) |
Inferred relationship |
Some |
1 |
Metipranolol 3 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metipranolol (substance) |
Inferred relationship |
Some |
1 |
Metipranolol-induced anterior uveitis (disorder) |
Causative agent (attribute) |
True |
Metipranolol (substance) |
Inferred relationship |
Some |
1 |